Altmetric

Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.

File Description SizeFormat 
Editorial_Final.pdfFile embargoed until 01 January 1000073.82 kBAdobe PDF    Request a copy
Title: Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.
Authors: Maher, TM
Dejonckheere, F
Nathan, SD
Item Type: Journal Article
Abstract: DISCLOSURES: Maher has received grants, consulting fees, and speaker fees from GlaxoSmithKline and UCB and grants from Novartis. He has also received consulting fees and speaker fees from AstraZeneca, Bayer, Biogen Idec, Boehringer Ingelheim, Cipla, Lanthio, InterMune International AG (a wholly owned Roche subsidiary since 2014), F. Hoffmann-La Roche, Sanofi-Aventis, and Takeda. Maher is supported by a National Institute for Health Research Clinician Scientist Fellowship (NIHR Ref: CS:-2013-13-017). Dejonckheere is an employee of F. Hoffmann-La Roche. Nathan has received consulting fees from Roche-Genentech and Boehringer Ingelheim. He is also on the speakers bureau for Roche-Genentech and Boehringer Ingelheim and has received research funding from both companies. All authors contributed equally to study concept and design, data collection and analysis, and manuscript preparation.
Issue Date: 1-Mar-2017
Date of Acceptance: 1-Mar-2017
URI: http://hdl.handle.net/10044/1/48985
DOI: 10.18553/jmcp.2017.23.3-b.s3
ISSN: 2376-1032
Publisher: Academy of Managed Care Pharmacy
Start Page: S3
End Page: S4
Journal / Book Title: J Manag Care Spec Pharm
Volume: 23
Issue: 3-b Suppl
Copyright Statement: All material is protected by copyright and may not be reproduced, republished, transmitted, or distributed without prior written permission, unless indicated otherwise. If you wish to copy or quote from JMCP, please contact Jennifer Booker @703.317.0725 or jmcpreview@amcp.org.
Keywords: Anti-Inflammatory Agents, Non-Steroidal
Humans
Hypertension, Pulmonary
Idiopathic Pulmonary Fibrosis
Indoles
Phosphodiesterase 5 Inhibitors
Pyridones
Survival Rate
Publication Status: Published
Conference Place: United States
Embargo Date: publication subject to indefinite embargo
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons